Safety, tolerability, and pharmacokinetics of repeated oral doses of 2-hydroxybenzylamine acetate in healthy volunteers: a double-blind, randomized, placebo-controlled clinical trial

被引:0
作者
Lisa M. Pitchford
Patricia M. Driver
John C. Fuller
Wendell S. Akers
Naji N. Abumrad
Venkataraman Amarnath
Ginger L. Milne
Sheau-Chiann Chen
Fei Ye
L. Jackson Roberts
M. Benjamin Shoemaker
John A. Oates
John A. Rathmacher
Olivier Boutaud
机构
[1] MTI BioTech,Department of Kinesiology
[2] Inc.,Department of Medicine, Division of Clinical Pharmacology
[3] Iowa State University,Department of Pharmaceutical Sciences
[4] Vanderbilt University Medical Center,Department of Pharmacology, Division of Clinical Pharmacology
[5] Lipscomb University College of Pharmacy,Department of Surgery
[6] Vanderbilt University,Department of Biostatistics
[7] Vanderbilt University Medical Center,Department of Medicine, Division of Cardiology
[8] Vanderbilt University Medical Center,Department of Animal Science
[9] Vanderbilt University Medical Center,undefined
[10] Iowa State University,undefined
来源
BMC Pharmacology and Toxicology | / 21卷
关键词
Safety; Pharmacokinetics; Humans; Salicylamine; γ-Ketoaldehydes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] A phase I, randomized, double-blind, placebo-controlled, ascending single- and multiple-dose study of the pharmacokinetics, safety, and tolerability of oral ceftibuten in healthy adult subjects
    Hernandez-Mitre, Maria Patricia
    Wallis, Steven C.
    Morgan, Elizabeth E.
    Dudley, Michael N.
    Loutit, Jeffery S.
    Griffith, David C.
    Roberts, Jason A.
    Shields, Ryan K.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (01)
  • [32] Safety, tolerability and pharmacokinetics of WXFL10203614 in healthy Chinese subjects: A randomized, double-blind, placebo-controlled phase I study
    Huang, Kai
    Ding, Ying
    Que, Linling
    Chu, Nannan
    Shi, Yunfei
    Qian, Zhenzhong
    Qin, Wei
    Chen, Yuanxin
    Gu, Xianghong
    Wang, Jiakun
    Zhang, Zhiwei
    Xu, Jianguo
    He, Qing
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [33] Safety and Pharmacokinetics of Lisdexamfetamine Dimesylate in Adults With Clinically Stable Schizophrenia A Randomized, Double-Blind, Placebo-Controlled Trial of Ascending Multiple Doses
    Martin, Patrick
    Dirks, Bryan
    Gertsik, Lev
    Walling, David
    Stevenson, Annette
    Corcoran, Mary
    Raychaudhuri, Aparna
    Ermer, James
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (06) : 682 - 689
  • [34] No negative symptoms in healthy volunteers after single doses of amisulpride, aripiprazole, and haloperidol: a double-blind placebo-controlled trial
    Park, Chul-Hyun
    Park, Tae-Won
    Yang, Jong-Chul
    Lee, Keon-Hak
    Huang, Guang-Biao
    Tong, Zhao
    Park, Myung-Sook
    Chung, Young-Chul
    INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2012, 27 (02) : 114 - 120
  • [35] Safety, Tolerability and Pharmacokinetics of Sodium Tungstate (OXO-001) in Healthy Female Volunteers of Childbearing Age: A Randomized, Double-Blind, Dose-Finding, and Placebo-Controlled Phase I Study
    Arbat, Agnes
    Canals, Ignasi
    Coimbra, Jimena
    Molina-Perello, Pol
    Llorens, Marta
    Torres, Rosa
    Perello, Josep
    Moral-Blanch, Marta
    Antonijoan, Rosa M.
    Calaf, Joaquim
    INTERNATIONAL JOURNAL OF FERTILITY & STERILITY, 2025, 19 (02) : 177 - 185
  • [36] Double-blind, randomized, placebo-controlled study of safety, tolerability, pharmacokinetics and pharmacodynamics of TAK-683, an investigational metastin analogue in healthy men
    Scott, Graham
    Ahmad, Irfan
    Howard, Katy
    MacLean, David
    Oliva, Cristina
    Warrington, Steve
    Wilbraham, Darren
    Worthington, Paul
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2013, 75 (02) : 381 - 391
  • [37] Randomized, double-blind, placebo-controlled, multiple-dose study of the safety, tolerability and pharmacokinetics of benvitimod, a candidate drug for the treatment of psoriasis
    Zhao, L.
    Chen, X.
    Cai, L.
    Zhang, C.
    Wang, Q.
    Jing, S.
    Chen, G.
    Li, J.
    Zhang, J.
    Fang, Y.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2014, 39 (04) : 418 - 423
  • [38] A randomized, double-blind, placebo-controlled study to evaluate the effect of repeated oral doses of pazopanib on cardiac conduction in patients with solid tumors
    Heath, Elisabeth I.
    Infante, Jeffrey
    Lewis, Lionel D.
    Luu, Thehang
    Stephenson, Joe
    Tan, Antoinette R.
    Kasubhai, Saifuddin
    LoRusso, Patricia
    Ma, Bo
    Suttle, A. Benjamin
    Kleha, Joseph F.
    Ball, Howard A.
    Dar, Mohammed M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (03) : 565 - 573
  • [39] A randomized, double-blind, placebo-controlled study to evaluate the effect of repeated oral doses of pazopanib on cardiac conduction in patients with solid tumors
    Elisabeth I. Heath
    Jeffrey Infante
    Lionel D. Lewis
    Thehang Luu
    Joe Stephenson
    Antoinette R. Tan
    Saifuddin Kasubhai
    Patricia LoRusso
    Bo Ma
    A. Benjamin Suttle
    Joseph F. Kleha
    Howard A. Ball
    Mohammed M. Dar
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 565 - 573
  • [40] Safety and antifatigue effect of Korean Red Ginseng: a randomized, double-blind, and placebo-controlled clinical trial
    Zhang, Li
    Chen, Xiaoyun
    Cheng, Yanqi
    Chen, Qilong
    Tan, Hongsheng
    Son, Dongwook
    Chang, Dongpill
    Bian, Zhaoxiang
    Fang, Hong
    Xu, Hongxi
    JOURNAL OF GINSENG RESEARCH, 2019, 43 (04) : 676 - 683